Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Blood Cell Transplant in Spinal Cord Injury
NCT01354483Phase 2Completed
- Sponsor
- China Spinal Cord Injury Network
- Start
- Sep 2011
- Primary completion
- Sep 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood mononuclear cells in spinal cord injury (SCI), sponsored by China Spinal Cord Injury Network. Started Sep 2011; status: completed.
02
Drugs
umbilical cord blood mononuclear cells
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT01354483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01354483.